Everest Medicines’ Nefecon® Advances Toward Approval for IgA Nephropathy Treatment in Taiwan

Everest Medicines’ Nefecon® Advances Toward Approval for IgA Nephropathy Treatment in Taiwan

Shanghai-based biopharmaceutical company Everest Medicines has announced that its New Drug Application (NDA) for Nefecon® has been accepted for review…